IQVIA Holdings Inc.

NYSE:IQV Rapporto sulle azioni

Cap. di mercato: US$43.1b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

IQVIA Holdings Performance dei guadagni passati

Il passato criteri di controllo 4/6

IQVIA Holdings ha registrato una crescita degli utili a un tasso medio annuo di 36.9%, mentre il settore Life Sciences ha registrato utili in crescita a un tasso medio annuo di 14.2%. I ricavi sono stati in crescita a un tasso medio annuo di 8%. Il ritorno sul capitale proprio di IQVIA Holdings è 21.2% e ha margini netti di 9.4%.

Informazioni chiave

36.9%

Tasso di crescita degli utili

38.0%

Tasso di crescita dell'EPS

Life Sciences Crescita del settore21.5%
Tasso di crescita dei ricavi8.0%
Rendimento del capitale proprio21.2%
Margine netto9.4%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

Sep 22
IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't

IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate

Sep 08
IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate

Reiterating Buy On IQVIA After Q2 Earnings

Aug 20

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 11
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Jul 30
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well

Jul 18
These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well

An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

Jun 04
An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

IQVIA: Long-Term Compounder Throwing Off Free Cash Flow

May 27

Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Apr 24
Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

Apr 11
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Mar 27
IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

Mar 14
Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Jan 23
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

Dec 24
Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Dec 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

Nov 23
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

IQVIA Q3: TAS Segment Remains The Problem Child

Nov 21

IQVIA: I Would Stay Away Until Debt Issues Are Resolved

Nov 12

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

Oct 08
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term

Sep 07

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Sep 04
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

Aug 11
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

IQVIA Holdings Q2: Breaking Ground And Beating Expectations

Aug 03

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

Jun 27
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

Jun 05
IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

IQVIA Holdings: A Possible Beat And Raise Scenario In The Works

May 23

What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

May 04
What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Mar 19
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Mar 05
Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

Feb 12
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

IQVIA Q4 2022 Earnings Preview

Feb 09

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Jan 29
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader

Jan 24

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Nov 09
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth

Nov 02

IQVIA Q3 2022 Earnings Preview

Oct 25

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Oct 02
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)

Sep 19

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 22
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US

Aug 11

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Aug 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same

Jul 28

Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

Jul 26
Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance

Jul 21

IQVIA A Smart Choice In A High-Inflation Environment

Apr 29

Ripartizione dei ricavi e delle spese

Come IQVIA Holdings guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

NYSE:IQV Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 2415,1551,4232,0650
31 Mar 2415,0691,3572,0380
31 Dec 2314,9841,3582,0430
30 Sep 2314,8551,1162,0470
30 Jun 2314,6811,0962,0620
31 Mar 2314,4941,0552,0630
31 Dec 2214,4101,0912,0380
30 Sep 2214,3071,1821,9970
30 Jun 2214,1361,1601,9780
31 Mar 2214,0331,0791,9770
31 Dec 2113,8749661,9310
30 Sep 2113,5367671,8860
30 Jun 2112,9316071,8480
31 Mar 2112,0144091,7970
31 Dec 2011,3592791,7620
30 Sep 2010,9561761,7590
30 Jun 2010,9391321,6940
31 Mar 2011,1582151,6990
31 Dec 1911,0881911,7110
30 Sep 1910,8812441,6690
30 Jun 1910,7062471,7030
31 Mar 1910,5332481,6910
31 Dec 1810,4122591,6920
30 Sep 1810,2451,2171,7380
30 Jun 1810,1171,2451,6990
31 Mar 189,9051,2461,6440
31 Dec 179,7021,2771,6050
30 Sep 179,133721,5280
30 Jun 177,804841,3450
31 Mar 176,6161081,1920
31 Dec 166,815721,0130
30 Sep 164,5403977610
30 Jun 164,4974097850
31 Mar 164,4044087950
31 Dec 154,3263878150
30 Sep 154,2623719020
30 Jun 154,2293528900
31 Mar 154,1913538830
31 Dec 144,1653577810
30 Sep 144,1063418900
30 Jun 143,9773158710
31 Mar 143,8862688800
31 Dec 133,8082278300
30 Sep 133,7501898430

Guadagni di qualità: IQV ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di IQV (9.4%) IQV sono più alti rispetto allo scorso anno (7.5%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di IQV sono cresciuti in modo significativo del 36.9% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di IQV nell'ultimo anno ( 29.8% ) è inferiore alla media quinquennale ( 36.9% all'anno).

Guadagni vs Settore: La crescita degli utili IQV nell'ultimo anno ( 29.8% ) ha superato la percentuale del settore Life Sciences -10.8%.

Rendimento del capitale proprio

ROE elevato: Sebbene il Return on Equity ( 21.19% ) di IQV sia elevato, questa metrica è distorta a causa del loro elevato livello di debito.

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate

7D

1Y

7D

1Y

7D

1Y